Last checked at 22 Oct 2021 07:00
22 October 2021
Microsaic Systems plc
("Microsaic" or the "Company")
Board Change
Microsaic (AIM: MSYS), announces that, after 6 years of service, Bevan Metcalf, will be retiring as Finance Director on 17 December 2021. To ensure a smooth transition, the Company has appointed an Interim Head of Finance (non-board level), until a permanent successor is appointed.
Gerry Brandon, Chairman commented:
"Bevan has been a valued colleague since 2015. He has played a valuable role in supporting the management team through his vast knowledge and experience working within industry and more recently in the development and recent turnaround of the Company. I would like to thank him for the tremendous contribution that he has made to Microsaic since his appointment as Finance Director more than 6 years ago. On behalf of our shareholders, advisors and everyone at Microsaic I would like to wish him a happy and healthy retirement."
Enquiries: | |
Microsaic Systems plc Glenn Tracey, CEO - Bevan Metcalf, FD
| +44 (0)1483 751 577 |
Singer Capital Markets (Nominated Adviser & Joint Broker) | +44 (0)20 7496 3000 |
Aubrey Powell / Tom Salvesen / George Tzimas
| |
Turner Pope Investments (TPI) Limited (Broker) Andy Thacker / James Pope | +44 (0) 20 3657 0050 |
About Microsaic
Microsaic listed on AIM in 2011 to develop and commercialise micro-engineering chip-based mass spectrometry equipment. Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need, whether within a human health environment, conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow.